MediciNova, Inc. (TYO:4875)

Japan flag Japan · Delayed Price · Currency is JPY
185.00
-2.00 (-1.07%)
Jul 18, 2025, 3:30 PM JST
-17.78%
Market Cap8.96B
Revenue (ttm)n/a
Net Income (ttm)-1.67B
Shares Outn/a
EPS (ttm)-34.07
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume35,600
Average Volume48,605
Open187.00
Previous Close187.00
Day's Range185.00 - 188.00
52-Week Range155.00 - 354.00
Betan/a
RSI40.27
Earnings DateAug 14, 2025

About MediciNova

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2b/3 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence a... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 13
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4875
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.